Source: Yahoo

Savara received $200M in Post-IPO Debt Funding

Followers on Owler

Annual Revenue

$100K-5.0M

Employees

25-100

Chairman & CEO

Matthew Pauls

CEO Approval Rating

88/100

Savara is a Texas-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of respiratory diseases.